Cytek Biosciences (CTKB) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Cytek Biosciences (CTKB) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -6.18% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 66.99% |
| 10 | Cytek Biosciences | - | - | 21.25 Mn | -36.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.94% |
| Dec 31, 2025 | 1,633.09% |
| Sep 30, 2025 | 47.88% |
| Jun 30, 2025 | 59.67% |
| Mar 31, 2025 | -111.42% |
| Dec 31, 2024 | -44.74% |
| Sep 30, 2024 | -230.84% |
| Jun 30, 2024 | -185.16% |
| Mar 31, 2024 | -34.69% |
| Dec 31, 2023 | -384.38% |
| Sep 30, 2023 | -614.90% |
| Jun 30, 2023 | -1,520.43% |
| Mar 31, 2023 | -352.36% |
| Dec 31, 2022 | -95.43% |
| Sep 30, 2022 | -68.10% |
| Jun 30, 2022 | -115.65% |
| Mar 31, 2022 | -232.34% |
| Dec 31, 2021 | -88.78% |
| Sep 30, 2021 | -99.80% |
| Jun 30, 2021 | 104.04% |